BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kay GN. Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy? J Nucl Cardiol 2019;26:1135-7. [PMID: 29761308 DOI: 10.1007/s12350-018-1299-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 AlJaroudi WA, Hage FG. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Positron emission tomography, computed tomography and magnetic resonance. J Nucl Cardiol 2020;27:921-30. [PMID: 32410058 DOI: 10.1007/s12350-020-02151-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Magnusson P, Nordström J, Harms HJ, Lubberink M, Gadler F, Sörensen J, Mörner S. Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. Int J Cardiol Heart Vasc 2020;26:100452. [PMID: 32140548 DOI: 10.1016/j.ijcha.2019.100452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]